Molecule intelOpportunity: LowerEssential

Isoflurane

15 brands · 11 companies · product forms

ATC: N01AB06 1 DRAP alert

Opportunity snapshot

Launch attractiveness
34
Market saturation
29
Price room
38
Regulatory risk
50
15
brands
11
companies
Rs 4,357.79
median price
12
price points
2.53x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 20%

Price room

Across observed sources and strengths
CheapestRs 4,010.76
MedianRs 4,357.79
Most expensiveRs 10,134.45
Spread2.53×
Sources: DRAP-official, Servaid

max/min price ratio 2.53x across 12 trusted points (Rs 4010.76-10134.45). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 8 live products for Isoflurane — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2022-12-01
Rapid Alert: Drug Product; Falsified Restane Inhalational Solution Identified and Confisca

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(38) + 20% low-competition(71) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

11 canonical companies and 15 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 2.53x across 12 trusted points (Rs 4010.76-10134.45). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2022-12-01 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.